Publication | Open Access

Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial

Malignant DiseaseMedicinePathologyMetastatic Progressive PhaeochromocytomasCancer TreatmentOncologyRadiation OncologyMolecular Oncology